Get the Stockscreener App
5.55
3.65%
-0.21
Sage Therapeutics Inc Stock (SAGE) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
89.87%
7.902
|
77.97 | 2.716 | 2.474 | 3.294 |
Operating Expenses
|
4.61%
125.58
|
120.05 | 214.56 | 172.93 | 158.76 |
| Benefits Costs and Expenses |
5.16%
116.39
|
110.68 | - | - | 150.12 |
| Costs And Expenses |
5.16%
116.39
|
110.68 | 214.56 | 172.93 | 158.76 |
| Operating Income/Loss |
179.69%
-117.67
|
-42.07 | -211.85 | -170.46 | -155.47 |
| Income/Loss From Continuing Operations Before Tax |
231.69%
-108.48
|
-32.71 | 2.716 | -160.32 | -146.83 |
| Income/Loss From Continuing Operations After Tax |
231.69%
-108.48
|
-32.71 | -201.63 | -160.32 | -146.83 |
|
Net Income/Loss
|
231.69%
-108.48
|
-32.71 | -201.63 | -160.32 | -146.83 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
119.72K%
60.14
|
0.0502 | 59.91 | 59.77 | 59.67 |
| Diluted Average Shares |
119.72K%
60.14
|
0.0502 | 59.91 | 59.77 | 59.67 |
| Basic Earnings Per Share |
233.33%
-1.80
|
-0.54 | -3.37 | -2.68 | -2.46 |
| Diluted Earnings Per Share |
233.33%
-1.80
|
-0.54 | -3.37 | -2.68 | -2.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):